company background image
CSL logo

CSL ASX:CSL Stock Report

Last Price

AU$284.27

Market Cap

AU$137.3b

7D

1.5%

1Y

-3.9%

Updated

21 Feb, 2024

Data

Company Financials +

CSL Stock Overview

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally.

CSL fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance4/6
Financial Health4/6
Dividends0/6

CSL Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CSL
Historical stock prices
Current Share PriceAU$284.27
52 Week HighAU$312.99
52 Week LowAU$228.65
Beta0.29
1 Month Change-2.15%
3 Month Change10.21%
1 Year Change-3.87%
3 Year Change6.09%
5 Year Change51.26%
Change since IPO35,434.11%

Recent News & Updates

CSL Limited's (ASX:CSL) Earnings Haven't Escaped The Attention Of Investors

Feb 02
CSL Limited's (ASX:CSL) Earnings Haven't Escaped The Attention Of Investors

Recent updates

CSL Limited's (ASX:CSL) Earnings Haven't Escaped The Attention Of Investors

Feb 02
CSL Limited's (ASX:CSL) Earnings Haven't Escaped The Attention Of Investors

Is CSL (ASX:CSL) Using Too Much Debt?

Dec 10
Is CSL (ASX:CSL) Using Too Much Debt?

CSL Limited (ASX:CSL) Shares Could Be 28% Below Their Intrinsic Value Estimate

Nov 16
CSL Limited (ASX:CSL) Shares Could Be 28% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That CSL (ASX:CSL) Is Using Debt Reasonably Well

Sep 11
These 4 Measures Indicate That CSL (ASX:CSL) Is Using Debt Reasonably Well

CSL Limited's (ASX:CSL) Intrinsic Value Is Potentially 47% Above Its Share Price

Aug 13
CSL Limited's (ASX:CSL) Intrinsic Value Is Potentially 47% Above Its Share Price

CSL (ASX:CSL) Has A Pretty Healthy Balance Sheet

May 30
CSL (ASX:CSL) Has A Pretty Healthy Balance Sheet

A Look At The Intrinsic Value Of CSL Limited (ASX:CSL)

May 09
A Look At The Intrinsic Value Of CSL Limited (ASX:CSL)

Does CSL (ASX:CSL) Have A Healthy Balance Sheet?

Mar 01
Does CSL (ASX:CSL) Have A Healthy Balance Sheet?

Estimating The Fair Value Of CSL Limited (ASX:CSL)

Feb 07
Estimating The Fair Value Of CSL Limited (ASX:CSL)

CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

Nov 17
CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

CSL Limited (ASX:CSL) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 27
CSL Limited (ASX:CSL) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Aug 19
We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Is CSL Limited (ASX:CSL) Trading At A 22% Discount?

Jul 29
Is CSL Limited (ASX:CSL) Trading At A 22% Discount?

CSL's (ASX:CSL) Problems Go Beyond Weak Profit

Feb 22
CSL's (ASX:CSL) Problems Go Beyond Weak Profit

Is CSL Limited (ASX:CSL) Worth AU$270 Based On Its Intrinsic Value?

Jan 19
Is CSL Limited (ASX:CSL) Worth AU$270 Based On Its Intrinsic Value?

With EPS Growth And More, CSL (ASX:CSL) Is Interesting

Dec 08
With EPS Growth And More, CSL (ASX:CSL) Is Interesting

CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

Oct 26
CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

We Think Shareholders Will Probably Be Generous With CSL Limited's (ASX:CSL) CEO Compensation

Oct 05
We Think Shareholders Will Probably Be Generous With CSL Limited's (ASX:CSL) CEO Compensation

Here's Why We Think CSL (ASX:CSL) Is Well Worth Watching

Sep 02
Here's Why We Think CSL (ASX:CSL) Is Well Worth Watching

CSL Limited (ASX:CSL) Shares Could Be 30% Above Their Intrinsic Value Estimate

Jul 22
CSL Limited (ASX:CSL) Shares Could Be 30% Above Their Intrinsic Value Estimate

CSL (ASX:CSL) Has A Pretty Healthy Balance Sheet

Jul 01
CSL (ASX:CSL) Has A Pretty Healthy Balance Sheet

Do CSL's (ASX:CSL) Earnings Warrant Your Attention?

May 20
Do CSL's (ASX:CSL) Earnings Warrant Your Attention?

We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Mar 29
We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Is Weakness In CSL Limited (ASX:CSL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 08
Is Weakness In CSL Limited (ASX:CSL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Shareholder Returns

CSLAU BiotechsAU Market
7D1.5%1.3%0.9%
1Y-3.9%-4.0%4.2%

Return vs Industry: CSL matched the Australian Biotechs industry which returned -4% over the past year.

Return vs Market: CSL underperformed the Australian Market which returned 4.2% over the past year.

Price Volatility

Is CSL's price volatile compared to industry and market?
CSL volatility
CSL Average Weekly Movement2.5%
Biotechs Industry Average Movement10.5%
Market Average Movement8.5%
10% most volatile stocks in AU Market16.7%
10% least volatile stocks in AU Market3.2%

Stable Share Price: CSL has not had significant price volatility in the past 3 months.

Volatility Over Time: CSL's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
191632,065Paul McKenziehttps://www.csl.com.au

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.

CSL Limited Fundamentals Summary

How do CSL's earnings and revenue compare to its market cap?
CSL fundamental statistics
Market capAU$137.33b
Earnings (TTM)AU$3.77b
Revenue (TTM)AU$21.64b

36.4x

P/E Ratio

6.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CSL income statement (TTM)
RevenueUS$14.18b
Cost of RevenueUS$6.86b
Gross ProfitUS$7.32b
Other ExpensesUS$4.85b
EarningsUS$2.47b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 13, 2024

Earnings per share (EPS)5.12
Gross Margin51.63%
Net Profit Margin17.43%
Debt/Equity Ratio54.4%

How did CSL perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

48%

Payout Ratio

Does CSL pay a reliable dividends?

See CSL dividend history and benchmarks
When do you need to buy CSL by to receive an upcoming dividend?
CSL dividend dates
Ex Dividend DateMar 11 2024
Dividend Pay DateApr 03 2024
Days until Ex dividend18 days
Days until Dividend pay date41 days

Does CSL pay a reliable dividends?

See CSL dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.